Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $311 Million - $551 Million
2,624,499 New
2,624,499 $471 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $8.44 Million - $13.9 Million
-71,455 Reduced 2.61%
2,670,708 $316 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $10.9 Million - $16.5 Million
93,359 Added 3.52%
2,742,163 $392 Million
Q1 2022

May 11, 2022

SELL
$126.46 - $235.05 $9.01 Million - $16.7 Million
-71,251 Reduced 2.62%
2,648,804 $456 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $530,677 - $865,998
2,350 Added 0.09%
2,720,055 $691 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $293 Million - $639 Million
1,319,143 Added 94.32%
2,717,705 $1.05 Billion
Q2 2021

Aug 11, 2021

BUY
$129.91 - $234.98 $15.9 Million - $28.8 Million
122,435 Added 9.59%
1,398,562 $329 Million
Q1 2021

May 13, 2021

SELL
$109.18 - $185.98 $1.85 Million - $3.15 Million
-16,961 Reduced 1.31%
1,276,127 $167 Million
Q4 2020

Feb 09, 2021

BUY
$65.74 - $169.86 $1.99 Million - $5.14 Million
30,262 Added 2.4%
1,293,088 $135 Million
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $10.7 Million - $18.7 Million
196,693 Added 18.45%
1,262,826 $89.3 Million
Q2 2020

Aug 12, 2020

BUY
$29.67 - $80.0 $12.4 Million - $33.3 Million
416,540 Added 64.12%
1,066,133 $68.5 Million
Q1 2020

May 06, 2020

BUY
$17.78 - $31.58 $1.18 Million - $2.1 Million
66,479 Added 11.4%
649,593 $19.5 Million
Q4 2019

Feb 14, 2020

BUY
$13.93 - $21.28 $1.15 Million - $1.75 Million
82,269 Added 16.43%
583,114 $11.4 Million
Q3 2019

Nov 07, 2019

BUY
$12.26 - $18.07 $5.59 Million - $8.24 Million
456,007 Added 1017.01%
500,845 $7.97 Million
Q2 2019

Aug 12, 2019

BUY
$13.7 - $28.34 $193,307 - $399,877
14,110 Added 45.92%
44,838 $657,000
Q1 2019

May 14, 2019

BUY
$14.45 - $23.7 $444,019 - $728,253
30,728 New
30,728 $625,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.